首页>
外国专利>
COMBINED USE OF RIBAVIRIN AND INTERFERON BETA DEMYELINATING DISEASES
COMBINED USE OF RIBAVIRIN AND INTERFERON BETA DEMYELINATING DISEASES
展开▼
机译:利巴韦林和干扰素β脱髓鞘疾病的联合使用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is in the field of neurological disorders. It relates to the use of ribavirin (1-D-D-ribofuranosyl-1H- 1,2, 4-triazole-3-carboxamide) in combination with an interferon (IFN) for the manufacture of a medicament for treatment and/or prevention of a demyelinating disease. In particular, it relates to the use of a combination of Ribavirin and IFN-beta for treatment and/or prevention of a demyelinating disease, such as multiple sclerosis.
展开▼